[sentNum: 1]Leading // Malignant neoplasm of breast // Mortality, Premature // Science of Etiology // Woman // 
[sentNum: 2]Early Diagnosis // To // Show // Reduced // Associated with // Morbidity - disease rate // Malignant neoplasm of breast // Mortality Vital Statistics // 
[sentNum: 3]objective (goal) // American Cancer Society // Update // Guideline [Publication Type] // Screening for malignant neoplasm of breast // At risk // Woman // Malignant neoplasm of breast // Average // 
[sentNum: 4]Review, Systematic // Processed // Malignant neoplasm of breast // Evidence of // Publications // Aspects of disease screening // Update // inform // Mammography // Supplement // Data Analysis // Registries // Question (inquiry) // Address // Aspects of disease screening // Relationships // Data Type Interval // 
[sentNum: 5]Drug Formulation Process // Base - General Qualifier // Recommendation // Evidence of // Quality // Values // Judgment // Balanced - adjective // preference // Benefits // 
[sentNum: 6]Evidence of // Screening mammography // Synthesis // Age // Woman // Arabic numeral 69 // /40 // Associated with // year // Primary malignant neoplasm // Reduction mammaplasty // Sample Range // Cessation of life // Inference // Research Design // Supportive assistance // Evidence of // Woman // Screening for malignant neoplasm of breast // Old // year // Personal Satisfaction // are unit of measure // 
[sentNum: 7]Cumulative // Estimated // False Positive // Lifetime Risk // Disease Screening // Largest // Young // Beginning // Largest // Age // Mammography // Numbers // Recall:-:Point in time:^Patient:- // High // Young // Rating (action) // Woman // 
[sentNum: 8]Quality // overdiagnosis // Evidence of // Sufficient // Negation // Lifetime Risk // Estimated // Confidence // 
[sentNum: 9]Analysis of substances // Disease Screening // Examining // Demonstrates // Data Type Interval // Favorable // More // Characteristics // Neoplasm // Woman // Premenopausal - menopausal status // Annual // Screening - procedure intent // 
[sentNum: 10]Negation // Evidence of // Health Checkup // Supportive assistance // Screening Method // Entire breast // Woman // Preposition For // Risk // Average // 
[sentNum: 11]Recommendation // Recommendation // Average // Woman // Malignant neoplasm of breast // Risk // Screening mammography // Regular // Age-Years // Beginning // Recommendation // Strong // 
[sentNum: 12]Age // Woman // Screening - procedure intent // year // Recommendation // Annual // 
[sentNum: 13]Arabic numeral 55 // Woman // Old // year // Disease Screening // Transition Mutation // Disease Screening // Continuous // Recommendation // Annual // 
[sentNum: 14]Beginning // Woman // Age // annual screening // year // /40 // Recommendation // 
[sentNum: 15]Woman // Disease Screening // Continuous // Long // Mammography // Health // Overall // antineoplaston A10 // Good // year // Life Expectancy // Recommendation // Long // 
[sentNum: 16]Recommendation // Negation // Screening for cancer // Clinical Breast Examination // Risk // Average // Age // Woman // Recommendation // 
[sentNum: 17]Conclusion // Update // Relevance // Providing (action) // Guideline [Publication Type] // Base - General Qualifier // Evidence of // Screening for malignant neoplasm of breast // Recommendation // Woman // Preposition For // Risk // Average // Malignant neoplasm of breast // 
[sentNum: 18]Recommendation // Physicians // consider // Discussion (procedure) // Woman // Screening for malignant neoplasm of breast // 
[sentNum: 19]Malignant neoplasm of breast // Primary malignant neoplasm // shared attribute // Woman // 
[sentNum: 20]United States // Woman // Estimated // Malignant neoplasm of breast // Diagnosis // Continuous // Malignant neoplasm of breast // Rank // To // Malignant neoplasm of lung // seconds // Primary malignant neoplasm // Cause of Death // Woman // Within // Leading // United States // Mortality, Premature // Science of Etiology // Woman // 
[sentNum: 21]Cessation of life // account - ActClass // Malignant neoplasm of breast // Potential // year // Lost // Life // year // Average // Lost // Life // Cessation of life // 
[sentNum: 22]Mortality Vital Statistics // 1990s // Malignant neoplasm of breast // Improvement // Due to // Therapeutic procedure // Early Diagnosis // /40 // Estimated // United States // Woman // Malignant neoplasm of breast // Cessation of life // 
[sentNum: 23]Update // Screening for malignant neoplasm of breast // Risk // Average // Scientific Publication // Woman // New // &gt;5 // Longterm Follow-up // Evidence of // Observational Study // Randomized Controlled Trials as Topic // Population Based Study // Organized // Services // Disease Screening // Programs - Publication Format // Disease Screening // 
[sentNum: 24]Now (temporal qualifier) // Add - instruction imperative // Estimated // Largest // Disease Screening // Associated with // Ability to balance // Assessed // Supportive assistance // Benefits // preference // Values // Decision Making // Informed // Recommendation // 
[sentNum: 25]standards characteristics // Institutes // Recommendation // protocol development // Guideline [Publication Type] // More // Ensure (product) // Translucent // Trustworthiness // Processed // Consistent with // Guideline [Publication Type] // Does communicate // 
[sentNum: 26]
[sentNum: 27]Guidelines // New // Organized // Developmental Process // Guidelines // Interdisciplinary Studies // Groups // Development // Clinician // Consistency // Biostatistician - NUCCProviderCodes // N not otherwise specified Antibody // Epidemiologist // N not otherwise specified Antibody // Economist // N not otherwise specified Antibody // Patient Representatives // N not otherwise specified Antibody // N not otherwise specified Antibody // 
[sentNum: 28]Guidelines // Groups // Development // Question (inquiry) // Integer +5 // General Population // Use of // To specify // Approach // Comparison // Intervention regimes // Timing // Result // {Setting} // Result // Preposition For // Picot // Question (inquiry) // 
[sentNum: 29]Evaluation // Methods // Availability of // Evidence of // Grade // Recommendation // STRENGTH (attribute) // Development // Guidelines // Choose (action) // Groups // Recommendation // Grade // Development // Assessed // System // Evaluation // 
[sentNum: 30]Recommendation // Grade // Development // Assessed // Accepted // Evaluation // Definition // Approach // Values // consideration // Address // preference // Capacity // Patient-Focused Outcomes // Within // Pliability // research outcome // Evaluation // Marital separation // Observational Study // Evidence of // Quality // Recommendation // STRENGTH (attribute) // 
[sentNum: 31]
[sentNum: 32]Duke Method for Bleeding Time Measurement // Choose (action) // Evidence of // Universities // Population Group // Synthesis // Independence // Behavior // Evidence of // Review, Systematic // Disease Screening // Malignant neoplasm of breast // Response process // Publications // proposal - intent // Request - action // 
[sentNum: 33]Referring // Exertion // Evidence of // To // Review [Publication Type] // 
[sentNum: 34]Add - instruction imperative // Update // Breast Cancer Surveillance Consortium // Analysis // Scientific Publication // Disease Screening // Relationships // Result // Parameterized Data Type - Interval // 
[sentNum: 35]Health Services Research // Medical Surveillance // Data // Providing (action) // Burden // breast and cervical cancer disease program // Data // Use of // epidemiologic // Medical Surveillance // Experimental Result // Stop (qualifier value) // Program // 
[sentNum: 36]
[sentNum: 37]Evidence of // Recommendation // Reading Frames (Nucleotide Sequence) // Grade // Professional guide // Balanced - adjective // Domain (area of knowledge) // Diversity // Result // Values // Woman // Self Confidence // preference // Effect // Magnitude // Result // 
[sentNum: 38]ALYREF gene // Choose (action) // Identifier // Assessed // To // Strong // Recommendation // Advice // Grade // 
[sentNum: 39]Recommendation // Strong // Benefits // Consensus // Intervention regimes // Adherence (attribute) // aspects of adverse effects // 
[sentNum: 40]Recommendation // Evidence of // Clear // Less Than // Benefits // Balanced - adjective // Certain (qualifier value) // Patients // Benefits // preference // Values // Different // Dietary Lead // Table - furniture // Decision // 
[sentNum: 41]Voting // member // Discord // Agreement // And // Recommendation // Recommendation // STRENGTH (attribute) // 
[sentNum: 42]Voting // Records // Make - Instruction Imperative // Question (inquiry) // Attribution // 
[sentNum: 43]Laboratory Order Panels // To // Attempt // Possibly Related to Intervention // Agreement // Quarter // Three // consider // majority // Vision // Acceptable // Supplement // 
[sentNum: 44]Diagnosis Type - Final // Publications // Guidelines // Extrinsic // Relevance // To // Organization administrative structures // Review [Publication Type] // Extrinsic // Guidelines // 
[sentNum: 45]Response process // Reviewed // Documented // Narration // ResponseLevel - modification // Recommendation // 
[sentNum: 46]Details // Developmental Process // Guidelines // Supplement (document) // Providing (action) // 
[sentNum: 47]Participant // All // Developmental Process // Guidelines // To // Requirement // personal relationship // Financial (qualifier) // Relationships // Practice Experience // Perception // Activities // Interested // Conflict (Psychology) // Malignant neoplasm of breast // Development // Guidelines // Aspects of disease screening // 
[sentNum: 48]Responsible to // Chairperson // Balanced - adjective // Ensure (product) // Decision Making // consider // 
[sentNum: 49]List // Disclosure // Information // Article // Disclosure // section sample // Reporting // Journalist // Supplement // 
[sentNum: 50]Question (inquiry) // Evidence of // Guide device // Review [Publication Type] // 
[sentNum: 51]This // Base - General Qualifier // Evidence of // Guideline [Publication Type] // Screening for malignant neoplasm of breast // Average // Woman // Focal // Risk // Original // Question (inquiry) // Protective cup // 
[sentNum: 52]Protective cup // ALYREF gene // section sample // Identifier // 
[sentNum: 53]Protective cup // 
[sentNum: 54]Guide device // Question (inquiry) // Review [Publication Type] // Evidence of // 
[sentNum: 55]Address // Question (inquiry) // Update // Guideline [Publication Type] // 
[sentNum: 56]Benefits // Relative // Associated with // Limitation // Comparison // Screening mammography // Average // Disease Screening // Woman // Risk // year // /40 // Age // Old // Data Type Interval // Disease Screening // Disease Screening // Prior Medication Usage // History of previous events // 
[sentNum: 57]Average // Woman // Risk // Mammography // Screening - procedure intent // Benefits // Relative // Associated with // Limitation // Disease Screening // Annual // Age // Data Type Interval // 
[sentNum: 58]Limitation // Benefits // Clinical Breast Examination // Associated with // Risk // Average // year // Woman // Comparison // Old // Age // Clinical Breast Examination // Participation // Data Type Interval // Screening mammography // Rating (action) // 
[sentNum: 59]Question (inquiry) // 
[sentNum: 60]4a serotype // Increase // Woman // Malignant neoplasm of breast // Risk // Known // Factor // Onset of (contextual qualifier) // Before // Egypt // Disease Screening // Mutation Carrier // Family History Domain // Radiotherapy to breast // History of previous events // Benefits // Relative // Associated with // Limitation // Disease Screening // Different // Comparison // Modality // Age // Disease Screening // Beginning // To // Disease Screening // Stop (qualifier value) // Comparison // 
[sentNum: 61]Serotype 4b // Increase // Woman // Malignant neoplasm of breast // Risk // Identified // Factor // Diagnosis Study // Growth Inhibition Screening Result // Prior diagnosis // Egypt // Lesion // Proliferation (morphologic abnormality) // Limitation // Benefits // Different // Associated with // Modality // Aspects of disease screening // Aspects of disease screening // Comparison // Comparison // 
[sentNum: 62]Maxillary right first premolar abutment // Increase // Woman // Malignant neoplasm of breast // Risk // Known // Factor // Onset of (contextual qualifier) // Before // Egypt // Disease Screening // Mutation Carrier // Family history // Radiotherapy to breast // History of previous events // Benefits // Relative // Associated with // Limitation // Disease Screening // Different // Different // Modality // Age // Interval // 
[sentNum: 63]Increase // Woman // Malignant neoplasm of breast // Risk // Identified // Factor // Diagnosis Study // Growth Inhibition Screening Result // Prior diagnosis // Egypt // Lesion // Proliferation (morphologic abnormality) // Limitation // Benefits // Different // Associated with // Modality // Aspects of disease screening // Interval // Different // Age // 
[sentNum: 64]Relative // Limitation // Benefits // Screening mammography // Associated with // Disease Screening // Comparison // Risk // Average // /40 // Woman // Old // year // Disease Screening // Age // Prior Medication Usage // Data Type Interval // History of previous events // Disease Screening // 
[sentNum: 65]Risk // Average // Screening - procedure intent // Woman // Relative // Mammography // Limitation // Benefits // Annual // Associated with // Data Type Interval // Disease Screening // Age // 
[sentNum: 66]Benefits // Associated with // Limitation // Average // Clinical Breast Examination // Woman // Risk // Old // year // Clinical Breast Examination // Comparison // Data Type Interval // Age // Rating (action) // Participation // Screening mammography // 
[sentNum: 67]ALYREF gene // Evidence of // Purpose // consider // Act Class - review // Risk // Average // Personal Attribute // Woman // Confirmation // History of malignant neoplasm of breast // Mutation // Suspected qualifier // To // Known // Risk // Increase // Egypt // Malignant neoplasm of breast // Previous // History of previous events // To // Therapeutic radiology procedure // Young // Anterior thoracic region // Age // 
[sentNum: 68]Woman // Categories // Risk // Money or percentage indicator - Percentage // A little bit // Woman // 
[sentNum: 69]AN 3 // Woman // Estimated // Invasive // Survivors // /40 // Malignant neoplasm of breast // Old // year // Total // Approximate // Estimated // Prevalence aspects // Diagnosis // Receive // Malignant neoplasm of breast // In situ // To // Expected // To // Increase // General Population // Million // Ashkenazi Jew, follower of religion // 2+ Score // Estimated // Woman // Genetic Carriers // To // Overall // BRCA2 Gene Mutation // Age // Screening mammography // Largest // Woman // Malignant neoplasm of breast // Lifetime Risk // Risk Assessment // Base - General Qualifier // Computer software // Medical Specialities // Family history // Dependent - ability // 
[sentNum: 70]2010s // And // Arabic numeral 55 // Estimated // United States // Woman // Moderation // Treated with // High-LET Radiotherapy // To // Pediatric discipline // Anterior thoracic region // Primary malignant neoplasm // Young Adult // 
[sentNum: 71]Extrinsic // Woman // Categories // Risk // Average // Abnormally high // Malignant neoplasm of breast // Risk // Mammography // And // Less Than // alone - group size // Including (qualifier) // Effective // Significant // Woman // Negation // Family history // Probability // Abnormally high // Mutation Carrier // Identified // Prior diagnosis // Woman // Proliferation (morphologic abnormality) // Benign // Woman // Breast Diseases // Mammographic breast density // Significant // 
[sentNum: 72]no // Time // Estimated // Reliability (characteristic) // Woman // Numbers // More // 1+ Score // Accepted // risk factors // Base - General Qualifier // Risk // Recommendation // Disease Screening // Intermediate Risk // Woman // Comparison // Population Group // Risk // Average // Woman // 
[sentNum: 73]Providing (action) // Entire breast // Recommendation // Disease Screening // Magnetic Resonance Imaging // Preposition For // Mammography // High risk of // Woman // Mutation // Base - General Qualifier // To // Known // Risk // Increase // History of previous events // Malignant neoplasm of breast // To // Therapeutic radiology procedure // Age // Anterior thoracic region // Estimated // year // Approximate // Lifetime Risk // Definition // Largest // Model // Risk Assessment // Family History Domain // Dependent - ability // 
[sentNum: 74]Conclude Resin // Time // Insufficient (qualifier) // Evidence of // Magnetic Resonance Imaging // Recommendation // Preposition For // Disease Screening // Categories // Woman // Risk // Increase // Use of // Recommendation // Disease Screening // Magnetic Resonance Imaging // Lifetime Risk // Woman // 
[sentNum: 75]Additional // Two // Has focus // Question (inquiry) // Present // Growth Inhibition Screening Result // High risk of // Female Breast Carcinoma // Evidence of // consider // Act Class - review // 
[sentNum: 76]Arabic numeral 23 // Scientific Publication // Following // Recommendation // Update // Woman // Preposition For // Categories // Widening // Risk // Average // To // Planned // Additional // Act Class - review // Factor // Evidence of // Increase // Associated with // Including (qualifier) // Risk // Growth Inhibition Screening Result // Breast Density // Disease Screening // Update // Woman // Recommendation // High risk of // Increase // 
[sentNum: 77]Evidence of // Review, Systematic // 
[sentNum: 78]Consultation // Within // N not otherwise specified Antibody // Group A // Evidence of // Work // study planning // Study Section // 
[sentNum: 79]New // Agree // Negation // Meta Analysis (statistical procedure) // utilization qualifier // 
[sentNum: 80]Recent // Experimental Result // Meta Analysis (statistical procedure) // To // Used by // Efficacy Study // Estimated // Disease Screening // Associated with // Estimated // Negation // Due to // Effectiveness // Rating (action) // Variable (uniformity) // To // Exposure to // And // Mammography // Scientific Study // Persons // Delta (difference) // Study // Result // 
[sentNum: 81]consider // Benefits // Estimated // Use of // Disease Screening // Exposure to // Data // Observational Study // Disease Screening // Services // Population Based Study // Derivation // Disease Screening // National citizen // Large // Including (qualifier) // Databases // 
[sentNum: 82]Limitation // Concern // Good // Observational Study // Within // Accepted // Malignant neoplasm of breast // Clinical Study Case // Good // Disease Screening // Observational Study // Design // Consistent with // Experimental Result // majority // 
[sentNum: 83]study planning // Study Section // Evidence of // Responsibility // Full // Search - action // Publications // Interpretation Process // strategy // Evidence of // Histopathologic Grade // 
[sentNum: 84]Including (qualifier) // Scientific Study // Synthesis // Evidence of // Following // Fulfill // Inclusion // 
[sentNum: 85]Controlled Study // Pooled Sample // Including (qualifier) // Levels (qualifier value) // Patients // Review, Systematic // Meta Analysis (statistical procedure) // Levels (qualifier value) // Study // Meta Analysis (statistical procedure) // 
[sentNum: 86]Observational Study // Retrospective Cohort Study // Longitudinal Studies // Base - General Qualifier // Incidence Studies // Case-Control Studies // Mortality Vital Statistics // Scientific Publication // Cross-Sectional Studies // 2000s // Since // More // Including (qualifier) // Risk // Average // Woman // 
[sentNum: 87]Modeling // Scientific Study // Simulation // Singular // Scientific Study // Long-term // Estimated // Associated with // Result // Negation // Disease Screening // Use of // Address // Protocols documentation // Technology // 
[sentNum: 88]Result // Critical // Act Class - review // consider // Table - furniture // Providing (action) // Following // Including (qualifier) // Mortality Vital Statistics // Malignant neoplasm of breast // Life Expectancy // Perceived quality of life // overdiagnosis // False Positive // 
[sentNum: 89]Morbidity - disease rate // Result // Therapeutic procedure // Relationships // Exposure to radiation // Malignant neoplasm of breast // consider // Mammography // Including (qualifier) // Negation // Act Class - review // Evidence of // 
[sentNum: 90]consider // Result // STRENGTH (attribute) // Question (inquiry) // Human body // Overall Publication Type // Including (qualifier) // Evidence of // Rating (action) // Research Design // consideration // In addition to // Biases // Risk // Direct type of relationship // Consistency // STRENGTH (attribute) // Precision - characteristic // Magnitude // Relationship by association // Effect // 
[sentNum: 91]Experimental Result // Used by // Meta Analysis (statistical procedure) // Consistency // Evaluation // STRENGTH (attribute) // Precision - characteristic // Relationship by association // 
[sentNum: 92]Evidence of // Details // Summary (document) // Evidence of // Description // Methodology aspects // Review [Publication Type] // Guideline [Publication Type] // Scientific Publication // 
[sentNum: 93]
[sentNum: 94]Evidence of // Analysis // 
[sentNum: 95]Review [Publication Type] // Evidence of // Update // Breast Cancer Surveillance Consortium // Relationship by association // Scientific Publication // Interval // Screening mammography // Characteristics // neoplasm diagnosis // Menopausal Status // Age // Hormones // Postmenopausal state // To // utilization qualifier // Result // Measurement // Aspects of disease screening // Relationships // month // Interval // Used by // Kernel Bandwidth // Annual // Proxy // Scientific Publication // Aspects of disease screening // Analysis // Previous // 
[sentNum: 96]
[sentNum: 97]consideration // Initial (abbreviation) // Disease Screening // Decision // Burden // geographic population // Overall Publication Type // Disease // Age // And // Subgroup A Nepoviruses // Specific qualifier value // 
[sentNum: 98]Question (inquiry) // Address // Beginning // Age // Stop (qualifier value) // To // Examined // Disease Screening // Indicators // Range // Age // Including (qualifier) // incidence of cases // Specific qualifier value // Age-Specific Death Rate // Mortality Vital Statistics // Base - General Qualifier // incidence of cases // Potential // year // Lost // Life // 
[sentNum: 99]&lt;3 (qualifier value) // 
[sentNum: 100]Experimental Result // Recommendation // 
[sentNum: 101]Recommendation // Consensus // Base - General Qualifier // Benefits // Judgment // Disease Screening // Mammography // geographic population // Probably // Average // Woman // Risk // 
[sentNum: 102]Individual // preference // Values // Different // Dietary Lead // Age // Decision // Stop (qualifier value) // Beginning // Disease Screening // Disease Screening // Recommendation // Interval // To // Grade // Informed // allowing // Options // Decision Making // Box // 
[sentNum: 103]Box // ALYREF gene // Sectional Distribution // Identifier // 
[sentNum: 104]Box // 
[sentNum: 105]Guideline [Publication Type] // American Cancer Society // Screening for malignant neoplasm of breast // 
[sentNum: 106]Recommendation // Spatial guidance for medical procedure // Representation (action) // Preposition For // American Cancer Society // Average // Woman // Malignant neoplasm of breast // Risk // Personal Attribute // Woman // Suspected qualifier // History of malignant neoplasm of breast // Mutation // Confirmed by // To // Known // Risk // Increase // Egypt // Malignant neoplasm of breast // Previous // History of previous events // To // Therapeutic radiology procedure // Young // Anterior thoracic region // Age // 
[sentNum: 107]Recommendation // Known // Woman // Benefits // Potential // Associated with // Limitation // Screening for malignant neoplasm of breast // 
[sentNum: 108]
[sentNum: 109]Woman // Risk // Average // Regular // Malignant neoplasm of breast // Beginning // Screening mammography // Age-Years // 
[sentNum: 110]Strong // Recommendation // 
[sentNum: 111]alphanumeric label - 1A // 
[sentNum: 112]Age // Woman // Screening - procedure intent // year // Annual // 
[sentNum: 113]Recommendation // 
[sentNum: 114]1B // 
[sentNum: 115]Woman // year // Arabic numeral 55 // Transition Mutation // Old // Continuous // Disease Screening // Annual // Disease Screening // 
[sentNum: 116]Recommendation // 
[sentNum: 117]
[sentNum: 118]Woman // annual screening // Beginning // /40 // Age // year // 
[sentNum: 119]Recommendation // 
[sentNum: 120]Continuous // Woman // Mammography // Disease Screening // Overall // Long // Good // Health // Life Expectancy // antineoplaston A10 // Long // year // 
[sentNum: 121]Recommendation // 
[sentNum: 122]Negation // Clinical Breast Examination // Recommendation // Average // Screening for cancer // Woman // Risk // Age // 
[sentNum: 123]Recommendation // 
[sentNum: 124]Strong // Aa (Plant) // Consensus // Recommendation // Adherence (attribute) // Benefits // aspects of adverse effects // Intervention regimes // Growth Inhibition Screening Result // 
[sentNum: 125]Recommendation // Evidence of // Clear // Disease Screening // Benefits // Certain (qualifier value) // Less Than // Benefits // Balanced - adjective // Values // Patients // Dietary Lead // preference // Decision // Different // Disease Screening // 
[sentNum: 126]
[sentNum: 127]Woman // Risk // Average // Regular // Malignant neoplasm of breast // Beginning // Screening mammography // Age-Years // 
[sentNum: 128]Strong // Recommendation // 
[sentNum: 129]Recommendation // Woman // alphanumeric label - 1A // year // Age // Annual // Screening - procedure intent // 
[sentNum: 130]Recommendation // 
[sentNum: 131]Recommendation // Woman // 1B // year // Arabic numeral 55 // Transition Mutation // Old // Continuous // Disease Screening // Annual // Disease Screening // 
[sentNum: 132]Recommendation // 
[sentNum: 133]Recommendation // Beginning // Woman // Age // annual screening // year // /40 // 
[sentNum: 134]Recommendation // 
[sentNum: 135]Various patch test substance // consider // topic - ActClassContainer // Recommendation // Make - Instruction Imperative // Experimental Result // Beginning // Review [Publication Type] // Evidence of // Associated with // Benefits // Screening mammography // Regular // 
[sentNum: 136]Age // To // Disease Screening // Beginning // Burden // Reviewed // Human Age Group // Disease // Benefits // consider // Human Age Group // 
[sentNum: 137]Add - instruction imperative // Data Type Interval // Recommendation // Evaluation // Disease Screening // Breast Cancer Surveillance Consortium // Procedure findings:Finding:Point in time:^Patient:Narrative // In addition to // Analysis // Evidence of // Experimental Result // Review [Publication Type] // 
[sentNum: 138]Growth Inhibition Screening Result // Mammography // 
[sentNum: 139]Evidence of // consider // Act Class - review // Critical // Integer +5 // Mammography // Growth Inhibition Screening Result // Mortality Vital Statistics // Malignant neoplasm of breast // False Positive // Life Expectancy // Quality // overdiagnosis // Life Expectancy // Adjustment Action // 
[sentNum: 140]Show // Screening mammography // Associated with // To // Cancer Death Rate // Reduction mammaplasty // Research Design // Range // Observational Study // Including (qualifier) // Cohort Studies // trend analysis // Scientific Study // Case-Control Studies // Benefits // Statistical Significance // Table - furniture // 
[sentNum: 141]STRENGTH (attribute) // Invitation // Evidence of // Screening mammography // Exposure to // Usual // Comparison // Disease Screening // care activity // Reduced // Associated with // Mortality Vital Statistics // Malignant neoplasm of breast // To // Judge // Evidence of // Abnormally high // effect size // Act Class - review // Range // depend // Including (qualifier) // factor A // Clinical trial protocol document // Research Design // Disease Screening // geographic population // follow-up // Duration (temporal concept) // 
[sentNum: 142]Estimated // Pool (action) // Encounter due to breast reduction // Relative // Approximate // Cancer Death Rate // follow-up // year // Meta Analysis (statistical procedure) // Similarity // Randomization // Use of // Model // Effect // Laboratory Order Panels // Independence // Relative Risk // Arabic numeral 31 // Advisory Committees // CANADIAN // And // Relative Risk // Used by // Analysis // Effect // Immobile // Relative Risk // Model // 
[sentNum: 143]Effect // Pool (action) // Scientific Study // trend // Death Rate // Comparison // Introduction procedure // And // Program // Disease Screening // Range // Reporting // To // Risk Reduction // 
[sentNum: 144]Base - General Qualifier // Incidence Studies // Pool (action) // Mortality Vital Statistics // Reduction - action // Mortality Vital Statistics // Woman // Arabic numeral 69 // Arabic numeral 69 // Disease Screening // Disease Screening // Attending (provider role) // 
[sentNum: 145]Estimated // Pool (action) // Arabic numeral 31 // Case-Control Studies // Arabic numeral 65 // Arabic numeral 69 // subscriber - self // Individual Adjustment // Selection, Genetic // 
[sentNum: 146]
[sentNum: 147]Magnitude // Numbers // Estimated // Including (qualifier) // factor A // Basis - conceptual entity // Estimated // Disease Screening // Invitation // Disease Screening // Exposure to // Heterogeneity // Degree or extent // Scientific Study // Persons // Pooled Sample // Meta Analysis (statistical procedure) // research outcome // Observation - diagnostic procedure // 
[sentNum: 148]Followed by // Analysis // Treatment intent // intent // Known // To // Biases // Unknown // 
[sentNum: 149]Evaluation // Observational Study // Disease Screening // Invitation // Disease Screening // Exposure to // Appropriate // In addition to // Known // Individual Adjustment // Biases // 
[sentNum: 150]Foundations // Evidence of // Supportive assistance // Conclude Resin // Screening mammography // Good // Large // Observational Study // Design // Information // Providing (action) // Associated with // Effectiveness // Mammography // 
[sentNum: 151]Robinow syndrome, autosomal recessive // Absolute // Estimated // Measured to (attribute) // Benefits // Needs // Numbers // Needs // Numbers // To // Screening - procedure intent // 1+ Score // PREVENT (product) // Meaning // Cessation of life // Benefits // Measures // 
[sentNum: 152]Absolute // Magnitude // Scientific Publication // Benefits // Duration (temporal concept) // Publications // Mortality Vital Statistics // follow-up // Estimated // Population at Risk // Estimated // Derivation // Needs // Numbers // Needs // Numbers // Screening - procedure intent // 
[sentNum: 153]Numbers // Estimated // Needs // Negation // Observational Study // utilization qualifier // Very // Estimated // Indicator // Woman // Cessation of life // No formal education // Aspects of disease screening // Aspects of disease screening // 
[sentNum: 154]Use of // Needs // Numbers // Needs // Numbers // Model // Screening - procedure intent // Result // Input // Absolute // Estimated // Benefits // 
[sentNum: 155]Example // Estimated // Review, Systematic // Woman // 2000s // To // Needs // follow-up // Aspects of disease screening // Mortality Vital Statistics // Preposition For // Period (temporal qualifier) // per year // 1+ Score // PREVENT (product) // Cessation of life // Malignant neoplasm of breast // 
[sentNum: 156]Act Class - review // Independence // Woman // Estimated // To // Needs // per year // Screening - procedure intent // Beginning // Period (temporal qualifier) // In addition to // Age-Years // Age-Years // follow-up // PREVENT (product) // To // Malignant neoplasm of breast // 1+ Score // Cessation of life // 
[sentNum: 157]Arabic numeral 31 // systematic // Main // Estimated // Independence // Base - General Qualifier // FORMER // Mortality Vital Statistics // Favorable // Over (spatial) // Reduction - action // Duration of screening // Short // year // Program // Use of // year // Needs // Numbers // Period (temporal qualifier) // follow-up // Aspects of disease screening // Definite time // Program // 
[sentNum: 158]Show // Absolute Change // Estimated // shared attribute // Benefits // Aspects of disease screening // Numbers // Duration (temporal concept) // Round shape // Then // follow-up // Standard Population // Application procedure // Risk // Baseline // Independence // Example // scenario // Act Class - review // Upper // described // Estimated // Arabic numeral 31 // From // Fold Change // Present // 2000s // Known // Good // PREVENT (product) // Arabic numeral 31 // Malignant neoplasm of breast // 1+ Score // Reduced // Cessation of life // Woman // Sample Range // To // Screening - procedure intent // 1+ Score // PREVENT (product) // Cessation of life // Malignant neoplasm of breast // 
[sentNum: 159]Estimated // Longterm Follow-up // per year // Evidence of // Swedish // follow-up // County // Two // Research Personnel // Clinical Trials // Woman // Observed // /40 // Age // Needs // year // Screening - procedure intent // To // per year // Time 2 // PREVENT (product) // Period (temporal qualifier) // Cessation of life // Malignant neoplasm of breast // Decreased // Follow-up 1 year // At // Woman // follow-up // year // Woman // And // year // At // follow-up // 
[sentNum: 160]
[sentNum: 161]To // Absolute // Assessed // Aspects of disease screening // Benefits // Time periods // per year // Study Section // Evidence of // Prevalence aspects // Used by // Annual // Aspects of disease screening // Derivation // Arabic numeral 65 // incidence of cases // National Health Interview Survey // Mortality Vital Statistics // Base - General Qualifier // Estimated // Surveillance, Epidemiology, and End Results (SEER) Program // 1+ Score, WHO // PREVENT (product) // Cessation of life // Malignant neoplasm of breast // Different // Base - General Qualifier // Mortality Vital Statistics // Relative // Reduction - action // 
[sentNum: 162]Woman // /40 // Elderly (population group) // Range // year // /40 // In addition to // Reduction - action // Mortality Vital Statistics // Mortality Vital Statistics // 1770s // Reduction - action // 
[sentNum: 163]Woman // year // Elderly (population group) // In addition to // Range // Mortality Vital Statistics // /40 // Mortality Vital Statistics // Reduction - action // Reduction - action // 
[sentNum: 164]Woman // Arabic numeral 69 // Elderly (population group) // Range // year // /40 // In addition to // Reduction - action // Mortality Vital Statistics // Mortality Vital Statistics // 20/25 // Reduction - action // 
[sentNum: 165]Estimated // Benefits // Absolute // Favorable // More // Exposure to // Base - General Qualifier // Favorable // Aspects of disease screening // Increase // disorder prevalence // 
[sentNum: 166]Presentation // Estimated // Favorable // More // Projections and Predictions // follow-up // Long // year // 
[sentNum: 167]Act Class - review // Evidence of // Quality // Judge // Abnormally high // Evidence of // Views screening:Find:Pt:Breast:Doc:Mam // Reduced // Increase // Cancer Death Rate // Life Expectancy // 
[sentNum: 168]Base - General Qualifier // Numerous // Uncertainty // Estimated // Observation parameter // Mortality Vital Statistics // Degree or extent // Associated with // Reduction - action // Different // Aspects of disease screening // Interval // Age // Evidence of // Quality // Degree or extent // Preposition For // Relationships // STRENGTH (attribute) // Life Expectancy // Aspects of disease screening // To // consider // low // 
[sentNum: 169]Estimated // are unit of measure // Life Expectancy // Indirect // Definition // geographic population // Entire // Meaning // Limited (extensiveness) // Extrinsic // consider // Procedure context // 
[sentNum: 170]Contrast // Present // Gain // Individual // Life Expectancy // Mortality, Premature // Woman // Significant // Malignant neoplasm of breast // Average // Given name // year // Total // Lost // Life // Entire breast // Greater // High Prevalence // Comparison // Involvement with // Primary malignant neoplasm // Woman // 
[sentNum: 171]
[sentNum: 172]False Positive // Screening for malignant neoplasm of breast // shared attribute // 
[sentNum: 173]False Positive Result Medical Device Problem // shared attribute // Mental Recall // Experimental Finding // Diagnostic Imaging // Additional // 
[sentNum: 174]Money or percentage indicator - Percentage // A little bit // Mental Recall // Woman // biopsy characteristics // GORAB gene // Woman // majority // findings aspects // Benign // 
[sentNum: 175]Place // Weighing patient // False Positive // Greater // biopsy characteristics // Leading // 
[sentNum: 176]Woman // Reporting // Initiate (source type) // Breast Cancer Surveillance Consortium // Age-Years // Disease Screening // Screening - procedure intent // /40 // Digital Mammography // film (photographic) // Cumulative // unadjusted // SLC33A1 gene // Probability // Recall:-:Point in time:^Patient:- // False Positive // Disease Screening // year // Disease Screening // Annual // 
[sentNum: 177]Cumulative // per year // False Positive // Probability // Leading // Mammography // Advice // Biopsy // Cohort // Same // Disease Screening // Annual // 
[sentNum: 178]Integer +2 // Disease Screening // per year // year // Cumulative // Reduced // Less Than // incidence of cases // Recall:-:Point in time:^Patient:- // False Positive // Biopsy // False Positive // Arabic numeral 31 // 
[sentNum: 179]ALYREF gene // A-factor (Streptomyces) // Identifier // Appearance // Numbers // Associated with // To // Probability // Increase // Including (qualifier) // False Positive // Mammography // First (number) // Mammographic breast density // Greater // Postmenopausal state // Use of // Use of // Hormone Therapy // Screening - procedure intent // Digital X-ray // Long // Film Mammography // Disease Screening // Time Interval // Comparison // Lacking // Image // Mammography // suggestion // Previous // Associated with // Clear // False Positive // 
[sentNum: 180]
[sentNum: 181]Malignant Neoplasms // Detection // Screening - procedure intent // Negation // Malignant Neoplasms // Symptomatic // Light Emitting Diode Device Component // Disease Screening // Malignant neoplasm of breast // 
[sentNum: 182]Scientific Publication // Most // overdiagnosis // Scientific Study // Estimated // Base // Comparison // Empiric // Inferior // Morbidity - disease rate // Observed // Disease Screening // incidence of cases // Projections and Predictions // Disease Screening // Absence (morphologic abnormality) // 
[sentNum: 183]Availability of // Estimated // From // Publications // To // 
[sentNum: 184]Estimated // Modeling // overdiagnosis // Lower - spatial qualifier // Scientific Study // empirical study // 
[sentNum: 185]Modeling // Empiric // Scientific Study // Simulate composite resin // Data // Estimated // natural history of disease // Base - General Qualifier // overdiagnosis // Risk // Comparison // Diagnosis Study // Clinical.estimated // Cessation of life // Science of Etiology // Time // Scientific Study // Event // 
[sentNum: 186]Research Design // utilization qualifier // Estimated // Biases // Methods // follow-up // Inadequate (qualifier) // trends qualifier // Personal failure // Dietary Lead // incidence of cases // Leading // Time // Estimated // Economic Inflation // 
[sentNum: 187]Study // Scientific Publication // Providing (action) // Direct (qualifier) // Policy // Reliability (characteristic) // Measurement // Relevance // Lower - spatial qualifier // overdiagnosis // Fraction of // Estimated // To // Malignant Neoplasms // Scientific Study // Base - General Qualifier // Sufficient // Including (qualifier) // Control Groups // follow-up // incidence of cases // Data // Absence (morphologic abnormality) // Expected // Adjustment Action // Disease Screening // Time // Dietary Lead // Potential // Age // 
[sentNum: 188]
[sentNum: 189]Evidence of // Quality // Consequence of // overdiagnosis // Judge // Screening mammography // Abnormally high // To // Act Class - review // Evidence of // Very // GIVEN // Range // Widening // Quality // Estimated // Preposition For // Evidence of // Estimated // Quantitative // overdiagnosis // Magnitude // To // Judge // Abnormally low (qualifier value) // 
[sentNum: 190]overdiagnosis // Most // Representation (action) // Associated with // Possible diagnosis // Experimental Result // Disease Screening // Magnitude // Uncertainty // overdiagnosis // Risk // Providing (action) // Challenge // Accurate (qualifier) // Complete // Woman // Information // Screening for malignant neoplasm of breast // To // 
[sentNum: 191]Adjustment Action // Quality // Life Expectancy // 
[sentNum: 192]Clinical Trials // Assessed // Observational Study // Malignant neoplasm of breast // Effect // Upon - dosing instruction fragment // Disease Screening // Quality-Adjusted Life Years // Woman // Availability of // Information // Base - General Qualifier // Publications // Scientific Study // Modeling // 
[sentNum: 193]Comparison // Show // Screening mammography // Disease Screening // Increase // Associated with // Degree or extent // Quality-Adjusted Life Years // Disease Screening // Increase // Beginning // Interval // Age // Stop brand of fluoride // Most // Disease Screening // Health // Model // Associated with // Utilities (organization) // Screening mammography // 
[sentNum: 194]Quality // Quality-Adjusted Life Years // Evidence of // Study Subject // Wiskott-Aldrich Syndrome // shared attribute // Limitation // Scientific Study // Modeling // Data Quality // And // Modeling // Used by // Relationships // Observation parameter // Utilities (organization) // Health // Effect // Negative // Unmarried person // Disease Screening // Limited (extensiveness) // Scientific Publication // Biospecimen // small size // Mammography // Outdated // Technology // 
[sentNum: 195]Recent // Collection (action) // Study // health information // More // False Positive // Utilities (organization) // United States // Woman // Duration (temporal concept) // Negation // Disease Screening // Not Applicable // Short-term // Relationships // Health // Reduction - action // Well Differentiated // Utilities (organization) // biopsy characteristics // Woman // Physical Examination // Repeat // 
[sentNum: 196]Review [Publication Type] // Evidence of // Evidence of // Quality // Degree or extent // Preposition For // Different // Effect // strategy // Disease Screening // Judge // Quality-Adjusted Life Years // Abnormally low (qualifier value) // To // 
[sentNum: 197]Age // To // Cognitive function: initiation // Recommendation // Burden // Disease Screening // Examined // Disease // Age Categories [Disease/Finding] // per year // Evidence of // In addition to // Age Categories [Disease/Finding] // Benefits // 
[sentNum: 198]Malignant neoplasm of breast // incidence of cases // To // Beginning // Age-Years // Increase // To // Continuous // Age // Increase // Table - furniture // year // 
[sentNum: 199]Beginning // Age // majority // Disease Screening // Including (qualifier) // Design // Old age // Woman // year // /40 // Burden // Base - General Qualifier // Result // Disease // Reporting // 
[sentNum: 200]Evidence of // Data // Observation - diagnostic procedure // Similarity // Show // Benefits // Relative (related person) // Invitation // Associated with // Disease Screening // Exposure to // /40 // Woman // Recall:-:Point in time:^Patient:- // Rate // Woman // Biopsy // film (photographic) // Screening - procedure intent // Similarity // Digital Mammography // 
[sentNum: 201]Judgment // Arabic numeral 65 // Benefits // Absolute // per year // Mammography // Woman // Human Age Group // Comparison // /40 // Old age // Woman // Definition // year // To // debate // Disease Screening // Beginning // 
[sentNum: 202]Risk Estimate // per year // Increase // Malignant neoplasm of breast // Span - parameter // Age // Risk // per year // Old age // Woman // Woman // year // year // Old age // Similarity // 1+ Score // Woman // Greater Than // /40 // Old age // Table - furniture // year // 
[sentNum: 203]incident // Proportion // geographic population // Malignant neoplasm of breast // Age // Similarity // year // year // Woman // Comparison // /40 // Old age // alphanumeric label - 1A // year // Malignant neoplasm of breast // Distribution // Belarus // Cessation of life // Comparison // Age at diagnosis // Old age // Woman // year // /40 // 1B // 
[sentNum: 204]Add - instruction imperative // Specific qualifier value // Age-Years // Base - General Qualifier // incidence of cases // Life // Persons // Similarity // Lost // Old age // Woman // year // year // Time // At // Approximate // Diagnosis // Account number:Identifier:Point in time:^Patient:Nominal // Together // year // Persons // Lost // Life // Follow-up status // year // 
[sentNum: 205]Burden // This // Indicated // Disease // Comparison // Traditional origin // Present // Woman // Woman // /40 // year // Woman // Similarity // Older Population // per year // Adjacent // Age // 
[sentNum: 206]Evidence of // Judge // Act Class - review // Evidence of // Quality // Mortality Vital Statistics // Relative // Associated with // Reduction - action // Woman // Screening mammography // year // Young // Quality // Abnormally high // Magnitude // Evidence of // Moderation // Effect, Appearance // 
[sentNum: 207]Reporting // Review, Systematic // Aspects of disease screening // Invitation // /40 // Woman // Old // year // Reduction mammaplasty // Associated with // In addition to // Cancer Death Rate // Magnitude // Greater // Observed // Benefits // Elderly (population group) // Woman // year // Arabic numeral 69 // Comparison // Randomization // Elderly (population group) // Woman // year // /40 // 
[sentNum: 208]Synthesis // Evidence of // Advisory Committees // Preventive service healthcare // Comparison // Recommendation // per year // Woman // Observed // Human Age Group // Arabic numeral 68 // Robinow syndrome, autosomal recessive // Elderly (population group) // Woman // year // /40 // Arabic numeral 69 // year // year // 
[sentNum: 209]Contrast // Base - General Qualifier // Incidence Studies // Case-Control Studies // Mortality Vital Statistics // Show // To // More // Greater // Reduction - action // Similarity // Groups // Age-Specific Death Rate // Age // Base - General Qualifier // Diagnosis Study // 
[sentNum: 210]Evaluation // Belarus // Aspects of disease screening // Direct (qualifier) // Age at diagnosis // Question (inquiry) // Address // Specific qualifier value // Age // Overcome // Benefits // population migration // Problem of aging // Evaluation // Within // 
[sentNum: 211]To // Human Age Group // /40 // controversy // Comparison // year // Swedish // Death Rate // Life // Female Breast Carcinoma // Woman // County // To // /40 // Death Rate // Screening for malignant neoplasm of breast // Life // Woman // Negation // County // /40 // Woman // Aspects of disease screening // 
[sentNum: 212]Status post // year // Average // Research Personnel // Follow-Up Report // Overall Publication Type // Observed // Reduction - action // Mortality Vital Statistics // Associated with // Arabic numeral 71 // Aspects of disease screening // Exposure to // Individual Adjustment // 
[sentNum: 213]Woman // /40 // Age // Mortality Vital Statistics // year // Observed // Reduction - action // Age // Woman // Mortality Vital Statistics // year // Observed // Reduction - action // 
[sentNum: 214]Early // Note (document) // Scientific Publication // Base - General Qualifier // Breast Cancer Surveillance Consortium // findings aspects // Base - General Qualifier // mostly // Growth Inhibition Screening Result // geographic population // film (photographic) // Screening - procedure intent // Cumulative // Digital Mammography // Rating (action) // per year // False Positive // Less Than // Resulting in // Bilateral // Diagnostic Imaging // Additional // Resulting in // Physical Examination // Similarity // Biopsy // Beginning // Disease Screening // /40 // Age-Years // Age-Years // 
[sentNum: 215]False Discovery Rate // Woman // Similarity // Disease Screening // Beginning // Comparison // Age-Years // /40 // Age-Years // Risk Estimate // Cumulative // Type - attribute // SLC33A1 gene // High // False Positive Result Medical Device Problem // Beginning // Disease Screening // Age // Young // Numbers // Increase // Screening Examination // 
[sentNum: 216]Digital Mammography // Screening - procedure intent // Replacement // United States // Film Mammography // Frequencies (time pattern) // Evidence of // Breast Cancer Surveillance Consortium // False Positive // Evidence-Based Practice // Pacific Northwest // Review, Systematic // Central // Screening for malignant neoplasm of breast // Update // Recommendation // 
[sentNum: 217]Base - General Qualifier // First (number) // Digital X-ray // Exclusion // Screening Examination // Inverse Association // Screening mammography // False Positive // Age // Woman // Screening Examination // /40 // Old age // Menopause // year // Human Age Group // per year // 
[sentNum: 218]Example // Arabic numeral 65 // Physical Examination // False Positive // Old age // Woman // year // /40 // Singular // year // Woman // Physical Examination // Biopsy // Recommendation // Woman // 
[sentNum: 219]Evidence of // Note (document) // Review [Publication Type] // Associated with // overdiagnosis // Age // Disease Screening // Evidence of // Quality // Magnitude // Estimated // overdiagnosis // Risk // Judge // Age // Abnormally low (qualifier value) // To // 
[sentNum: 220]Possibly Related to Intervention // Negation // overdiagnosis // Lifetime Risk // Beginning // Increase // Early // Disease Screening // 
[sentNum: 221]strategy // Aspects of disease screening // Reporting // consider // Malignant neoplasm of breast // From // Intervention regimes // Working Group // Consortium or Network // Surveillance Modeling // Singular // Cancer Intervention and Surveillance Modeling Network // Age Started // strategy // Annual // year // Age // Aspects of disease screening // year // Arabic numeral 69 // 
[sentNum: 222]Delta (difference) // Increment // Cessation of life // Malignant neoplasm of breast // False Positive // Number of biopsies // Extent // Woman // From // Growth Inhibition Screening Result // Arabic numeral 69 // Age-Years // Additional // Similarity // PREVENT (product) // Cessation of life // Biopsy // Additional // Screening - procedure intent // Woman // Extent // To // From // Aspects of disease screening // Arabic numeral 55 // Age-Years // 0/5 // Arabic numeral 69 // Cessation of life // Additional // Biopsy // Additional // 
[sentNum: 223]Similarity // Arabic numeral 69 // Extent // Evidence of // Age-Years // annual screening // Arabic numeral 69 // Arabic numeral 69 // Estimated // year // Cessation of life // Additional // Additional // Arabic numeral 31 // Woman // Biopsy // Comparison // Screening - procedure intent // annual screening // Extent // Age-Years // From // Arabic numeral 69 // Arabic numeral 55 // Additional // Estimated // Additional // Cessation of life // Woman // Biopsy // Screening - procedure intent // 
[sentNum: 224]Arabic numeral 69 // 
[sentNum: 225]Absence (morphologic abnormality) // Within // Evidence of // Direct type of relationship // Malignant neoplasm of breast // Comparison // Aspects of disease screening // Mortality Vital Statistics // Indirect // Interval // Including (qualifier) // Evidence of // Mathematical Model // Meta Analysis (statistical procedure) // Model // Observational Study // Formation // To // Data Type Interval // Recommendation // Aspects of disease screening // 
[sentNum: 226]Meta Analysis (statistical procedure) // Comparison // Screening Study // Human Age Group // Widening // year // Arabic numeral 69 // Interval // Aspects of disease screening // Present // month // Invitation // Benefits // Negation // Aspects of disease screening // Aspects of disease screening // Relationships // Woman // Interval // Arabic numeral 69 // Elderly (population group) // Randomization // year // 
[sentNum: 227]Randomization // Woman // Significant // Age-Years // Mortality Vital Statistics // Reduction - action // Singular // Observed // At // Invitation // month // Interval // More // Interval // Benefits // month // 1+ Score, WHO // Observed // 
[sentNum: 228]Two // Swedish // Clinical Trials // County // Screening - procedure intent // Woman // month // Interval // Research Personnel // Long // point - UnitsOfMeasure // To // Beginning // Malignant neoplasm of breast // Normal // To // Mammography // 
[sentNum: 229]Woman // year // Old // Entry (data) // At // Few // Study // Observed // Malignant neoplasm detection during interval between recommended screening examinations // year // First (number) // Elderly (population group) // Woman // year // /40 // Rate // Randomization // /40 // Malignant neoplasm detection during interval between recommended screening examinations // Incidence Rate // Control Groups // Normal first month // Within // Screening mammography // 
[sentNum: 230]
[sentNum: 231]Mathematical Model // Aspects of disease screening // Benefits // Estimated // Modeling // Detected (finding) // Ability // small size // Malignant Neoplasms // Model // Numerous // annual screening // suggestion // Associated with // Interval // Neoplasm // Detection // More // Greater // Lethal // effect size // 
[sentNum: 232]Arabic numeral 71 // Analysis of substances // Cancer Intervention and Surveillance Modeling Network // Screening mammography // Aspects of disease screening // Different // Experimental Result // Act Relationship Type - schedules // Model // Model // Choose (action) // Universities // Model // Research Personnel // Benefits // Equilibrium // More // Estimated // Cessation of life // Malignant Neoplasms // Comparison // Annual // Human Age Group // Aspects of disease screening // Numbers // Greater // Cessation of life // Malignant Neoplasms // Beginning // Aspects of disease screening // Age-Years // 
[sentNum: 233]Arabic numeral 69 // Benefits // Additional // Beginning // annual screening // Early // Aspects of disease screening // False Discovery Rate // High // Biopsy // Screening Examination // 
[sentNum: 234]Study // Cancer Intervention and Surveillance Modeling Network // Aspects of disease screening // Estimated // Maintaining (action) // per year // Mortality Vital Statistics // Average // annual screening // Benefits // Numbers // Half // False Positive // 
[sentNum: 235]Arabic numeral 69 // Negation // Model // strategy // Hybrids // Data Type Interval // Aspects of disease screening // Age // 
[sentNum: 236]Breast Cancer Surveillance Consortium // Annual // Relationships // Result // Disease Screening // definition - ActMoodCompletionTrack // Use of // More // Interval // month // Approximate // Early // Used by // Publications // Breast Cancer Surveillance Consortium // 
[sentNum: 237]Relationships // Examined // Interval // Disease Screening // Characteristics // Neoplasm // III (suffix) // Stage 2 lower case b // size // Greater // Anatomic Node // Positive Finding // More // 1+ Score, WHO // Indicators // Characteristics // Forecast of outcome // Favorable // 
[sentNum: 238]suggestion // Analysis of substances // Favorable // Somewhat // Associated with // Characteristics // Data Type Interval // Short // Age // Woman // year // /40 // Old // Negation // year // Woman // Not significant // Delta (difference) // 
[sentNum: 239]Analysis of substances // Additional // Experimental Result // Indicated // Menopausal Status // Probably // 
[sentNum: 240]Woman // Premenopausal - menopausal status // Probably // More // 1+ Score, WHO // Advanced phase // Greater // 1+ Score, WHO // 1+ Score, WHO // Tumor size // Prognosis bad // 1+ Score, WHO // 1+ Score, WHO // neoplasm diagnosis // Associated with // 1+ Score, WHO // Data Type Interval // Disease Screening // month // Arabic numeral 23 // Disease Screening // Comparison // month // Data Type Interval // 
[sentNum: 241]Observation in research // Degree or extent // Age // Due to // Status // Premenopausal - menopausal status // Disease Screening // Decreased Device Sensitivity // Woman // Young // combination of objects // A-factor (Streptomyces) // Uncertainty // 
[sentNum: 242]Journalist // Potential // Numerous // Analysis of substances // Limitation // Woman // Including (qualifier) // To // High risk of // Frequent // More // Analysis of substances // Disease Screening // Family history // Adjustment Action // Sample Size // Decision // Woman // Inclusion // To // Exposure to // film (photographic) // Screening - procedure intent // Involvement with // Digital Mammography // Experimental Result // 
[sentNum: 243]Overall Publication Type // Digital // Statistical sensitivity // Film Mammography // Screening - procedure intent // Digital Mammography // Similarity // Confidentiality - sensitive // More // Woman // Young // Dense breasts NOS // Woman // 
[sentNum: 244]
[sentNum: 245]Disease Screening // Decision Making // consider // Interval // Benefits // 
[sentNum: 246]annual screening // Reduced // Large // Mortality Vital Statistics // Screening for malignant neoplasm of breast // More // Arabic numeral 69 // Disease Screening // Frequent // High // Schedule (document type) // False Positive // Rating (action) // findings aspects // 
[sentNum: 247]GIVEN // Annual // Disease Screening // To // Appearance // Additional // Providing (action) // Disease Screening // Benefits // Woman // Young // Woman // Conclude Resin // year // Old age // Annual // Screening - procedure intent // Woman // Recommendation // /40 // Old age // Choose (action) // year // Initiation // To // Screening - procedure intent // Disease Screening // Recommendation // Annual // 
[sentNum: 248]Benefits // Relative // Disease Screening // Annual // Menopause // Less Than // Woman // And // Arabic numeral 69 // Old // Frequent // More // Carrying // Disease Screening // Chance // Increase // False Positive // Additional // Old age // Woman // year // Arabic numeral 55 // Large // Age // Woman // majority // Transition Mutation // Postmenopausal state // Continuous // Disease Screening // Annual // Disease Screening // Recommendation // 
[sentNum: 249]Woman // Disease Screening // Continuous // Long // Mammography // Health // Overall // antineoplaston A10 // Good // year // Life Expectancy // Long // 
[sentNum: 250]Recommendation // 
[sentNum: 251]incidence of cases // Malignant neoplasm of breast // To // Continuous // Age // Increase // Malignant neoplasm of breast // year // per year // Cessation of life // Diagnosis Study // Attribution // 1B // Age-Years // 
[sentNum: 252]Sensitivity and Specificity // &lt;3 (qualifier value) // Increasing // Mammography // suggestion // Age // Cessation of life // Further // Female Breast Carcinoma // Old // 
[sentNum: 253]Including (qualifier) // None // year // Woman // Modeling // Old // Reduction - action // Observed // Mortality Vital Statistics // Malignant neoplasm of breast // Mammography // Associated with // Malignant neoplasm of breast // Detection // year // Woman // findings aspects // Old // GIVEN // Interprets // Research Design // Limitation // 
[sentNum: 254]Reduced // ALYREF gene // Associated with // Life Expectancy // Reduced // Old // Disease Screening // Probability // Woman // Benefits // 
[sentNum: 255]Show // Observational Study // Women's Health // Old // Example // Poor - qualifier // Score // Comorbidity Index // Negation // Abnormally high // Reduction - action // Practice Experience // Mortality Vital Statistics // Malignant neoplasm of breast // Screening mammography // Associated with // Etiology // Due to // Good // Negation // Disease Screening // 
[sentNum: 256]Problem // Recent // Concern // suggestion // Scientific Study // Serious // Woman // Health conditions // End-stage // Screening mammography // Receive // Probability // low // Life Expectancy // Increasing // Result // Improving (qualifier value) // 
[sentNum: 257]Poor - qualifier // Women's Health // Co-morbid conditions // Severe (severity modifier) // Life Expectancy // Limited (extensiveness) // Disease Screening // More // Anxiety // Including (qualifier) // Associated with // Sensory Discomfort // Risk // Additional // Due to // overdiagnosis // Risk // Increase // Negation // Dying Process // Relationships // Malignant neoplasm of breast // Good // Etiology // Breast Cancer Therapeutic Procedure // 
[sentNum: 258]Health // Negation // Life Expectancy // consider // Age // Decision // Disease Screening // 
[sentNum: 259]Proportion // Significant // year // Woman // are unit of measure // Old // Expected // Personal Satisfaction // % live // To // year // Long // 
[sentNum: 260]2010s // Base - General Qualifier // Approximate // Life Tables // Old // per year // per year // Woman // Woman // Old // year // % live // 
[sentNum: 261]Mortality Vital Statistics // &lt;90 // utilization qualifier // % index // Comorbidity // Age // Long-term // Functional Status // Community // Mortality Vital Statistics // Old // Home environment // utilization qualifier // Woman // Judgment // Clinical // Old // Probability // Life Expectancy // Woman // Definition // year // Probability // Greater Than // year // SURVIVE // 
[sentNum: 262]Health // Woman // per year // Possess // Individualized // Life Expectancy // Screening mammography // Decision // consider // 
[sentNum: 263]Decision Aids // Old // Helping Behavior // Make - Instruction Imperative // Woman // Informed // Decision // Potential // Comprehension // Screening mammography // Benefits // 
[sentNum: 264]Surrounding (qualifier value) // Uncertainty // Old // Benefits // Probably // Woman // Health Priorities // Changing // Patient Preference // Time // Decision // Screening procedure // 
[sentNum: 265]Woman // Recommendation // Screening procedure // Continuous // Overall // Long // Good // Health // Life Expectancy // antineoplaston A10 // Long // year // 
[sentNum: 266]Recommendation // Negation // Screening for cancer // Clinical Breast Examination // Risk // Average // Age // Woman // 
[sentNum: 267]Recommendation // 
[sentNum: 268]Previous // Routine // recommendations or guidelines // Limitation // Clinical Breast Examination // Evidence of // 
[sentNum: 269]Question (inquiry) // Review [Publication Type] // Evidence of // Lacking // Present // Show // Evidence of // Benefits // Any // alone - group size // Clinical Breast Examination // Screening mammography // Conjunction // 
[sentNum: 270]Quality // Moderation // Add - instruction imperative // Evidence of // Screening mammography // Clinical Breast Examination // False Discovery Rate // Increase // 
[sentNum: 271]Identified // Scientific Study // Critical // Assessed // Result // 
[sentNum: 272]Supplement // Identified // Search - action // Clinical Breast Examination // Study Characteristics // Most // Performance // Add - instruction imperative // Show // Detected (finding) // Clinical Breast Examination // Numbers // A little bit // Malignant neoplasm of breast // Additional // Comparison // Integer +2 // alone - group size // Mammography // 
[sentNum: 273]Patient Outcome // No Information Available // Clinical Breast Examination // Better // 
[sentNum: 274]Lacking // GIVEN // Concurrent // Benefits // False Discovery Rate // Increase // Negation // Clinical Breast Examination // Screening for malignant neoplasm of breast // Recommendation // Risk // Average // Woman // Asymptomatic // Age // 
[sentNum: 275]Time // Usual // Restricted // Clinician // Clinic Visits // This // utilization qualifier // Family History Domain // Time // Woman // Counseling // Breast changes // Consciousness clear // Benefits // Potential // Screening mammography // Limitation // 
[sentNum: 276]Malignant neoplasm of breast // Proportion // Detection // subscriber - self // Contribution // Relative // Self-Examination // systematic // Unknown // Incidental Discovery // 
[sentNum: 277]Absent // Given name // Better // Evidence of // Associated with // Result // Guideline [Publication Type] // Self-Examination // Including (qualifier) // Negation // Routine // Recommendation // Educational process of instructing // Performance // Breast Self-Examination // 
[sentNum: 278]New // Report (document) // Scientific Study // year // Recent // Conclusion // 
[sentNum: 279]Availability of // Evidence of // Evidence of // Development // Needs // Quantitation // Guideline [Publication Type] // Associated with // Benefits // Screening for malignant neoplasm of breast // 
[sentNum: 280]Synthesis // Assortment // Evidence of // Including (qualifier) // Source // Services // Observational Study // Modeling // Disease Screening // Scientific Study // 
[sentNum: 281]Evidence of // Base // 
[sentNum: 282]Empiric // Disease Screening // Comparison // Term (temporal) // Programs - Publication Format // Beginning // Age // Disease Screening // Stop (qualifier value) // Interval // And // Lacking // Screening Examination // 
[sentNum: 283]Entire breast // Further // Negation // Screening Study // Estimated // Providing (action) // consider // Benefits // Span - parameter // Policy // Decade // Numerous // Persons // More // 
[sentNum: 284]Not Applicable // Numerical value // Screening mammography // Meta Analysis (statistical procedure) // Current (present time) // Professional guide // Retained // Health Policy // 
[sentNum: 285]Efficacy Study // Evidence of // Scientific Study // Screening mammography // 1960s // Behavior // 1990s // Through // Most // Protocols documentation // Old // Use of // film - layer // Screening - procedure intent // Frequent // System // Singular // Use of // Mammography // View // 
[sentNum: 286]Result // Sample Range // Reduction - action // Mortality Vital Statistics // Degree or extent // Term (temporal) // Disease Screening // Invitation // Reduced // Associated with // Diagnosis // Risk // Entire breast // Advanced Malignant Neoplasm // Reduced // Associated with // Mortality Vital Statistics // Malignant neoplasm of breast // 
[sentNum: 287]Overall // Arabic numeral 97 // Reduction - action // Age-Specific Death Rate // Derivation // Estimated // intent // Meta Analysis (statistical procedure) // Experimental Result // Treatment intent // Revealed // Negation // Delta (difference) // Theses // Clinical Trials // Performance // 
[sentNum: 288]Estimated // Add - instruction imperative // intent // Base - General Qualifier // Analysis of substances // Treatment intent // To // Non Adherence // Control Groups // Library Protocol // 
[sentNum: 289]Meta Analysis (statistical procedure) // respect // Sound - physical agent // Experimental Result // Judge // Basis // Screening mammography // Efficacy Study // Basis // Poor - qualifier // Effectiveness // Estimated // Quality // Value Above Reference Range // Calculation // Disease Screening // Benefits // Absolute // 
[sentNum: 290]Review [Publication Type] // Evidence of // Research Design // FAVOR // Ability // Theory // Biases // Providing (action) // Efficacy Study // Estimated // 
[sentNum: 291]Estimated // Deriving // Benefits // Absolute // Estimated // Means // Invitation // Basis - conceptual entity // Exposure to // Disease Screening // Contamination // Disease Screening // From // Cessation of life // Study // Women's Groups // Attending (action) // Negation // Disease Screening // 
[sentNum: 292]Providing (action) // Mortality Vital Statistics // Foundations // Basis - conceptual entity // Result // Disease Screening // Exposure to // Design // Good // Assessment service // Observational Study // View // Disease Screening // Statistical Confidence // Largest // 
[sentNum: 293]Methodology aspects // Observational Study // Study Subject // are unit of measure // Unknown // Known // Biases // 
[sentNum: 294]Example // Population Group // Comparison // Negation // Dissimilar // Differential quality // apparent // History // Disease Screening // Therapeutic procedure // Quality // Selection Bias // Different // Different // Other // Exposure to // Characteristics // Experimental Result // Persons // 
[sentNum: 295]care activity // In addition to // Possibly Related to Intervention // Attention // Validity (characteristic) // threat // Providing (action) // Observational Study // Relationships // Evidence of // Result // Disease Screening // Exposure to // Woman // Disease Screening // 
[sentNum: 296]Indication of (contextual qualifier) // Observation - diagnostic procedure // consider // Screening Study // Services // Population Group // Organized // Disease Screening // Base - General Qualifier // To // Scientific Study // Consistent with // Experimental Result // Reflecting // Better // Protocols documentation // Disease Screening // Evidence of // Providing (action) // Associated with // Benefits // Disease Screening // Exposure to // 
[sentNum: 297]Better // Breast Cancer Therapeutic Procedure // Leading // Time // Question (inquiry) // To // Advance // Negation // Aspects of disease screening // Therapeutic procedure // Less Than // 
[sentNum: 298]Small // Research Design // Evidence of // Support, device // 
[sentNum: 299]Berries // Model // GAGE7 wt Allele // Contribution // Relative // Therapeutic procedure // Aspects of disease screening // Approximate // Estimated // Reduction - action // Half // Mortality Vital Statistics // Malignant neoplasm of breast // Aspects of disease screening // Associated with // Associated with // Half // adjuvant therapy // Improvement // 
[sentNum: 300]Fraction of // Decrease in height // Associated with // Mortality Vital Statistics // Estimated // Aspects of disease screening // Program Evaluation // Aspects of disease screening // 
[sentNum: 301]Relative // Question (inquiry) // Therapeutic procedure // Contribution // Focal // Aspects of disease screening // Within // Advance // Clinical Study Case // Therapeutic procedure // Imaging Technology // Improvement // Occur (action) // quality assurance // /40 // Past // year // 
[sentNum: 302]Screening - procedure intent // System // film (photographic) // Time // Better // Replaced by // mostly // Digital Mammography // Full field // Resulting in // Unit of Measure // Improvement // Further // Performance // Imaging Techniques // Woman // Young // Dense // Woman // Digital breast tomosynthesis // 
[sentNum: 303]Data // To // Appearance // Improvement // Further // Sensitivity and Specificity // Accurate (qualifier) // Digital breast tomosynthesis // Data // Prevalence aspects // Increasing // Facility // Mammography // 
[sentNum: 304]Early Diagnosis // Time // Social Role // Therapeutic procedure // Malignant neoplasm of breast // Scientific Control // 
[sentNum: 305]Attempt // Negation // Relative // To // Aspects of disease screening // Contribution // Breast Cancer Therapeutic Procedure // Reduced // Cessation of life // 
[sentNum: 306]Negation // performance - action // Comparison // Film Mammography // Screening - procedure intent // Digital Mammography // Full field // Digital // Note (document) // Show // System // Better // To // Young // Statistical sensitivity // Woman // Woman // New // Dense // Show // Data // Deterioration of status // Slightly // Young // Specificity // Woman // Old // 
[sentNum: 307]Singular // Arabic numeral 65 // Fraction of // A little bit // Facility // Mammography // Screening - procedure intent // Use of // Unit of Measure // film (photographic) // Small // Comparison // Policy // Purpose // Decision Making // Persons // 
[sentNum: 308]Unit of Measure // DBT gene // Mammography // Introduces // Time // Facility // Evidence of // Library Protocol // Data // Review [Publication Type] // Including (qualifier) // DBT gene // 2-Dimensional // Comparison // Mammography // Three-dimensional // 
[sentNum: 309]Knowledge // Current (present time) // Risk // suggestion // Average // Categories // High risk of // Abnormally high // Always (frequency) // Negation // 
[sentNum: 310]Recommendation // Update // Woman // Preposition For // Followed by // High risk of // Guideline [Publication Type] // One // Some (qualifier value) // Plant Leaves // Screening mammography // Question (inquiry) // Woman // Preposition For // Risk // Increase // Diagnosis // Malignant neoplasm of breast // Advanced phase // More // 
[sentNum: 311]Woman // Time // suspected carrier // Known // Entire breast // Deleterious Mutation // Woman // Cancer-Predisposing Gene // Therapeutic radiology procedure // Treated with // Age // Young // To // Recommendation // Screening mammography // Beginning // Young // Multisection:Finding:Point in time:Breast:Narrative:MRI // Age // 
[sentNum: 312]risk factors // Negation // Family history // Predisposition // Identified // History of previous events // Linked gene // Stage 0 Breast Carcinoma // Invasive // Confirmed by // Biopsied lesion // Disease Screening // Proliferation (morphologic abnormality) // Current (present time) // Recommendation // Practice Experience // 
[sentNum: 313]Negation // Act Class - review // Including (qualifier) // Upon - dosing instruction fragment // Evidence of // Supplement // Effectiveness // Imaging Techniques // Entire breast // Dense breasts NOS // Woman // Some (qualifier value) // Place // High risk of // Female Breast Carcinoma // Malignant neoplasm of breast // High risk of // Detection // Negation // Mammography // 
[sentNum: 314]consider // Disease Screening // Evidence of // Present // Effectiveness // Risk // Women's Groups // Complete // Following // Guideline [Publication Type] // Update // Risk // Average // Woman // 
[sentNum: 315]Problem // controversy // overdiagnosis // Estimated // Sample Range // Rating (action) // Overall Publication Type // Fraction of // Relative // Attribution // overdiagnosis // Invasive // Noninfiltrating Intraductal Carcinoma // Woman // Disease // overdiagnosis // Possibly Related to Intervention // 
[sentNum: 316]Publications // Estimated // Any // Support, device // overdiagnosis // Positioning Attribute // Money or percentage indicator - Percentage // Any // Nonprogressive // Noninfiltrating Intraductal Carcinoma // 
[sentNum: 317]Review [Publication Type] // Evidence of // Evidence of // Judge // Abnormally high // overdiagnosis // Estimated // Evidence of // overdiagnosis // Degree or extent // Abnormally low (qualifier value) // 
[sentNum: 318]Arabic numeral 23 // Laboratory Order Panels // Independence // Uncertainty // Conclude Resin // Report (document) // Estimated // Artificial (qualifier value) // Experimental Result // Accurate (qualifier) // Impression // 
[sentNum: 319]
[sentNum: 320]Main // ALYREF gene // Screening mammography // Act Mood - Goal // To // Programs - Publication Format // Mortality Vital Statistics // Malignant neoplasm of breast // Incidence Rate // Reduced // Malignant neoplasm of breast // Advanced phase // 
[sentNum: 321]Screening mammography // Aim (idea) // Detected (finding) // To // Early // Malignant neoplasm of breast // Natural History // 
[sentNum: 322]Screening Tests // Detected (finding) // Successful // Invasive Malignant Neoplasm // Small // Precursor // Detected (finding) // Lesion // 
[sentNum: 323]Probably // overdiagnosis // Result // Instance // Butting // Time // Advance // Progressive // Diagnosis // Lesion // 
[sentNum: 324]Recent // Result // Reviewed // Diagnosis // Woman // Noninfiltrating Intraductal Carcinoma // Treated with // Noninfiltrating Intraductal Carcinoma // Conclude Resin // Disease // Invasive // respect // Heterogeneity // Characteristics // prognostic // Noninfiltrating Intraductal Carcinoma // Result // Invasive Malignant Neoplasm // Small // shared attribute // Sharing (Social Behavior) // 
[sentNum: 325]Biological Markers // Future // Helping Behavior // Identified // Therapeutic procedure // Present // Overcome // Decision Making // Nonprogressive // Current (present time) // One // Neoplasm // Progressive // Progressive // Less Than // Neoplasm // Neoplasm // Aggressive course // Aggressive course // More // 
[sentNum: 326]Biological Markers // New // To // Contribution // Individualized Medicine // Progress // Woman // Providing (action) // Therapeutic procedure // Counsel - legal // Choice Behavior // 
[sentNum: 327]
[sentNum: 328]GIVEN // Agreement // shared attribute // To // Woman // Needs // Screening for malignant neoplasm of breast // Communicating // Research Activities // Benefits // Information // Risk // Limitation // Disease Screening // Associated with // 
[sentNum: 329]Quality-Adjusted Life Years // Current state // Relationships // Publications // Point Name // Screening mammography // Needs // To // Research Activities // Future // Utilities (organization) // Better // Study // Evaluation procedure // Address // To // Woman // state of health // Processed // Practice Experience // Associated with // Screening mammography // Utilities (organization) // Health // Duration (temporal concept) // Time // 
[sentNum: 330]False Positive // High frequency // Screening mammography // From // More // United States // Needs // Study // Woman // Comprehension // Greater // are unit of measure // Near // Risk // Psychiatric problem // Long-term // False Positive // Associated with // strategy // High priority // Associated with // Stress // False Positive // 
[sentNum: 331]
[sentNum: 332]Update // intent // Recommendation // objective (goal) // Balanced - adjective // Burden // Reduced // Comprehension // Malignant neoplasm of breast // Prophylactic treatment // Screening for malignant neoplasm of breast // Application procedure // Health // eligible // Entire // Woman // Population Group // Negation // Most // Malignant neoplasm of breast // 
[sentNum: 333]Guideline [Publication Type] // Measurement // Some (qualifier value) // Requirement // Judgment // Balanced - adjective // Weighing patient // Benefits // 
[sentNum: 334]Evaluation // Disease // Burden // Evidence of // Availability of // Absolute // Relative // Aspects of disease screening // Benefits // Estimated // Age // Relative // Frequencies (time pattern) // Uncertainty // Known // allowing // Adverse event // Change values // Preposition For // preference // Woman // Potential // Relative // Decision // Benefits // Screening mammography // 
[sentNum: 335]ATTITUDE CHANGED // Screening for malignant neoplasm of breast // Benefits // Recommendation // Aspects of disease screening // Reflecting // Delta (difference) // 
[sentNum: 336]Recommendation // New // collective // Representation (action) // intent // Judgment // Providing (action) // To // Woman // Spatial guidance for medical procedure // Screening for malignant neoplasm of breast // Health Personnel // 
[sentNum: 337]Guideline [Publication Type] // Update // respect // Departure - action // Recommendation // Previous // Table - furniture // Screening for malignant neoplasm of breast // 
[sentNum: 338]New // View // Context // Evidence of // Choose (action) // Guideline [Publication Type] // Evidence of // To // Burden // Disease // Effectiveness // Effectiveness // Human Age Group // Disease Screening // Age // In addition to // /40 // Range // year // Arabic numeral 55 // Discord // Preposition For // Beginning // Age // Disease Screening // Disease Screening // Past // Data Type Interval // Decade // 
[sentNum: 339]Largest // Experience // Evidence of // More // described // Recall:-:Point in time:^Patient:- // From // Diagnostic Imaging // Additional // Term (lexical) // Biopsy // Effect // 
[sentNum: 340]Woman // Additional // Recall:-:Point in time:^Patient:- // Small // Diagnostic Imaging // Woman // Adverse effects // Largest // Practice Experience // Persistent // Sometimes // Adverse effects // 
[sentNum: 341]Judge // Values // Woman // Social Role // preference // Equilibrium // Decision // Benefits // Absolute // Certain (qualifier value) // Less Than // 
[sentNum: 342]Periodic // Recommendation // Woman // Clinical Breast Examination // /40 // Young // Annual // year // Woman // Clinical Breast Examination // year // /40 // Old // 
[sentNum: 343]Update // Clear // Absent // Clinical Breast Examination // Evidence of // Breast Cancer Detection Research // Contribution // /40 // Age-Years // Conclude Resin // Light Emitting Diode Device Component // Recommendation // Long // Risk // Average // Age // Woman // 
[sentNum: 344]Recommendation // New // Interprets // Negation // discount - ActCode // To // Numerical value // Potential // Abnormally low (qualifier value) // Clinical Breast Examination // Resources // Communications Media // Screening mammography // contextual factors // Negation // 
[sentNum: 345]Clinical Breast Examination // Women's Groups // Social Role // Risk // Very high // Address // Question (inquiry) // Recommendation // Update // Woman // High risk of // 
[sentNum: 346]Address // Negation // Negation // Breast Self-Examination // No status change // Recommendation // Guideline [Publication Type] // 
[sentNum: 347]Retained // Arabic numeral 55 // Continuous // Options // Woman // annual screening // Personal Attribute // Base - General Qualifier // Clinical // preference // Spatial guidance for medical procedure // Beginning // Mammography // annual screening // Transition Mutation // Age-Years // Age-Years // Disease Screening // 
[sentNum: 348]Aftercare // Disease // Burden // Elderly (population group) // Woman // year // /40 // Smaller // Conclude Resin // Burden // Negation // Woman // Disease // /40 // Elderly (population group) // High risk of // year // Result // Cumulative // Direct (qualifier) // Long // Beginning // Advice // Age-Years // Disease Screening // /40 // 
[sentNum: 349]Conclude Resin // Age // Women's Groups // Beginning // Choose (action) // Age-Years // Screening mammography // Age-Years // /40 // preference // Base - General Qualifier // consideration // 
[sentNum: 350]Woman // Potential // Numerical value // Benefits // Early Diagnosis // To // Willing // Risk // Accept - Source type // Testing // Additional // To // Choose (action) // Disease Screening // Beginning // Early // 
[sentNum: 351]Woman // To // Choose (action) // Beginning // Deferred // Base - General Qualifier // Disease Screening // Malignant neoplasm of breast // Low Risk // 
[sentNum: 352]annual screening // GIVEN // Appearance // Mammography // Providing (action) // To // Benefits // Additional // Young // Disease Screening // Recommendation // Woman // Old age // Woman // Screening - procedure intent // year // Woman // Annual // /40 // Old age // Choose (action) // year // Screening - procedure intent // To // Annual // Somalia // Arabic numeral 55 // Woman // Old // year // Disease Screening // Transition Mutation // Disease Screening // Continuous // Annual // 
[sentNum: 353]Guideline [Publication Type] // Benefits // Potential // Screening mammography // Continuous // Women's Health // Preposition For // Old // Good // Woman // year // Limited (extensiveness) // Life // Unlikely // Comorbidity // Disease Screening // Benefits // 
[sentNum: 354]Natures // Concern // Surrounding (qualifier value) // debate // Screening for malignant neoplasm of breast // 
[sentNum: 355]Extreme // Challenge // debate // Disease Screening // Numerical value // debate // More // Characterization // Characterization // Publications // Academia (organization) // Within // Communications Media // Benefits // Balanced - adjective // 
[sentNum: 356]Weighing patient // GIVEN // Screening mammography // Evidence of // Significant // Associated with // Within // Reduced // Dying Process // Risk // Malignant neoplasm of breast // From // /40 // Age-Years // Productivity // More // Focal // Discussion (communication) // Screening mammography // Performance // 
[sentNum: 357]Organized // Absence (morphologic abnormality) // United States // Disease Screening // Concept Attribute // Contribution // Screening Tests // 
[sentNum: 358]Example // Central // Lacking // Decision // Registries // Efficiency // Recall:-:Point in time:^Patient:- // Disease Screening // Woman // Adherence (attribute) // Meaning // Disease Screening // Recommendation // Suboptimal // 
[sentNum: 359]Variability // Mammography // Sensitivity and Specificity // Better // Better // Strong // Training Programs // Standards of Weights and Measures // Qualifying // Regular // Education, Continuing // Performance // Feedback - system communication // 
[sentNum: 360]Accurate (qualifier) // Better // Contribution // Sensitivity and Specificity // Benefits // Increase // Reduced // 
[sentNum: 361]Improving (qualifier value) // High // Role Class - access // Entire breast // Quality // Priority // Imaging Techniques // 
[sentNum: 362]BARRIER // United States // Continuous // Role Class - access // Exist // To // Uninsured // Low income // Usual // Woman // care activity // Source // Rural // Reside // County // 
[sentNum: 363]BARRIER // Obstetric Delivery // Challenge:Type:Point in time:^Patient:Nominal // Probably // Preventive service healthcare // Time // Somalia // Policy // Further // Changing // 
[sentNum: 364]Act Mood - intent // To // Patient Protection and Affordable Care Act // Screening mammography // Cost Sharing // Clarity // Lacking // Screening for malignant neoplasm of breast // Cover - action // And // Age // Recommendation // Interval // Decision Making, Shared // Informed // 
[sentNum: 365]Strong // Very // Average // Positioning Attribute // Woman // Risk // Face // Negation // Disincentives // financial // Screening mammography // Decision Making // Advice // Immobile // Proline // Weighing patient // Beginning // Concanavalin A // Screening procedure // age differences // Informed // Data Type Interval // Recommendation // Decision Making, Shared // 
[sentNum: 366]intended - ParticipationSignature // Guideline [Publication Type] // Providing (action) // To // Clinician // Spatial guidance for medical procedure // utilization qualifier // Design // Clinical setting // Present // Patient Visit // 
[sentNum: 367]Woman // Awareness // To // Family History Domain // To // Clinician // Medical History Domain // Woman // Periodic // Profile (lab procedure) // risk factors // Changing // 
[sentNum: 368]Woman // Risk // Average // Discussion (procedure) // Malignant neoplasm of breast // around // Screening procedure // /40 // Age-Years // 
[sentNum: 369]Woman // Recommendation // Information // Providing (action) // Risk Reduction // risk factors // Limitation // Benefits // Screening mammography // Associated with // 
[sentNum: 370]Recommendation // Conclusion // Context // Make - Instruction Imperative // Malignant neoplasm of breast // Reduction (chemical) // Reduced // Mortality Vital Statistics // Life // year // Associated with // Lost // Woman // geographic population // United States // 
[sentNum: 371]Balanced - adjective // Closed // Benefits // Spectrum // Instance // Values // Woman // Dietary Lead // preference // Decision // 
[sentNum: 372]intent // Guideline [Publication Type] // New // Providing (action) // To // Pliability // Spatial guidance for medical procedure // To // Woman // Stop (qualifier value) // Beginning // Frequent // Screening mammography // Screening for malignant neoplasm of breast // 
